Skip to main content

c-erbB-2 (human), (recombinant)

BML-SE460

  • BML-SE460-0010   —   10 µg
    $507.00

c-erbB2 is best known in its role in breast cancer, where it is amplified in approximately 20% of invasive cancers. The humanized monoclonal antibody, trastuzumab, and the small molecule, lapatinib, inhibit c-erbB2.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only